Third, only two of the genes included in the signature, SLC2A1 (Martínezterroba et al., 2018) and PFKP (Lee et al., 2016) have previously been evaluated as prognostic markers for lung adenocarcinoma. Here, PFKP is linked to lung adenocarcinoma.